Position in FTRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,174,540
-$2,638,710 QoQ
Shares Held
337,000
0.0% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NATIONAL BANK OF CANADA /FI/ holds $751,526,651 across 111 Biotechnology names. FTRE ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
6,298,000 | $174,454,600 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
1,749,000 | $170,090,250 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
272,117 | $121,511,122 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,006 | $100,447,834 | |
| 5 | MRNA |
Moderna, Inc.
|
1,817,001 | $92,303,650 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
63,607 | $21,045,647 | |
| 7 | ASND |
Ascendis Pharma A/S
|
80,017 | $18,302,288 | |
| 8 | INSM |
INSMED Inc
|
104,758 | $17,130,027 |
All Filings in FTRE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,174,540 | 337,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,813,250 | 337,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,675,580 | 199,000 | Shares | Defined | 2025-11-14 | |
| 2024-06-30 | $1,120 | 48 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $1,926 | 48 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $21,742 | 623 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $25,816 | 903 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $6,972 | 205 | Shares | Defined | 2023-07-26 | |
| No filing history on record for this holder in this stock. | ||||||